BridgeBio Pharma (BBIO) Cash & Equivalents Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | 29.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.26% |
| Dec 31, 2025 | 14.81% |
| Sep 30, 2025 | -16.30% |
| Jun 30, 2025 | 16.79% |
| Mar 31, 2025 | 13.31% |
| Dec 31, 2024 | 20.04% |
| Sep 30, 2024 | 13.88% |
| Jun 30, 2024 | 2.54% |
| Mar 31, 2024 | 0.29% |
| Dec 31, 2023 | 1,293.26% |
| Sep 30, 2023 | 11.25% |
| Jun 30, 2023 | -17.62% |
| Mar 31, 2023 | -18.66% |
| Dec 31, 2022 | 1.17% |
| Sep 30, 2022 | 5.29% |
| Jun 30, 2022 | 16.96% |
| Mar 31, 2022 | -0.13% |
| Dec 31, 2021 | -3.35% |
| Sep 30, 2021 | -5.21% |
| Jun 30, 2021 | 14.46% |
| Dec 31, 2020 | -88.53% |